Xtx Topco LTD Sorrento Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $264,830 - $654,918	357,879 New	357,879 $318,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $96,525 - $181,374	77,843 Added 404.34%	97,095 $195,000
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $2,270 - $5,561	1,135 Added 6.26%	19,252 $45,000
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $84,244 - $130,985	18,117 New	18,117 $84,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.